Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 6035-6037, December 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by London, S. J.
Right arrow Articles by Idle, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by London, S. J.
Right arrow Articles by Idle, J. R.

Lung Cancer Risk in African-Americans in Relation to a Race-specific CYP1A1 Polymorphism1

Stephanie J. London2, Ann K. Daly, Karen S. Fairbrother, Clair Holmes, Catherine L. Carpenter, William C. Navidi and Jeffrey R. Idle

Division of Occupational and Environmental Medicine [S. J. L., C. L. C.], and Department of Preventive Medicine, Division of Biostatistics [W. C. N.], University of Southern California School of Medicine, Los Angeles, California 90033; and the Department of Pharmacological Sciences, University of Newcastle, Medical School, Newcastle NE2 4HH, United Kingdom [A. K. D., K. S. F., C. H., J. R. I.]

The possible association between lung cancer and a polymorphism of the CYP1A1 gene specific to African-Americans was examined using peripheral blood DNA from 144 incident cases of lung cancer and 230 population controls with detailed data on smoking and other risk factors for the disease. The CYP1A1 variant allele was present in 15.2% of controls and 16.7% of cases. The smoking-adjusted odds ratio for the presence of the variant allele in relation to lung cancer risk overall was 1.3 (95% confidence interval, 0.7–2.4). According to histological type, the strongest association was observed for squamous cell carcinoma (odds ratio, 2.1), but this result was compatible with chance (95% confidence interval, 0.8–5.9). Adenocarcinoma was not materially associated with the presence of the variant allele (odds ratio, 1.3; 95% confidence interval, 0.5–3.2). No important associations were observed upon stratification by several risk factors for lung cancer, including smoking history, occupational exposures to asbestos and motor vehicle exhaust, or low intake of the micronutrient antioxidants ß-carotene, vitamin E, or vitamin C. These results do not confirm an earlier report that this CYP1A1 polymorphism may be an important risk factor for adenocarcinoma of the lung in African-Americans.

1 This work was supported by Grants 1RT-140 and 3RT-0403 from the State of California Tobacco Related Disease Research Program. S. J. L. was also supported by a Research Career Development Award from Stop Cancer. Case ascertainment was supported in part by the California Public Health Foundation, subcontract 050-F-8709, which is supported by the California Department of Health Services as part of its statewide cancer-reporting program mandated by Health and Safety Code Sections 210 and 211.3. Case ascertainment was also supported in part by the Division of Cancer Prevention and Control, National Cancer Institute, NIH, United States Department of Health and Human Services, under contract number N01-CN-25403.

2 To whom requests for reprints should be addressed, at National Institute for Environmental Health Sciences, P.O. Box 12233, Mail Drop A3-05, Research Triangle Park, NC 27709.

Received 9/19/95. Accepted 11/ 1/95.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little
Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review
Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.L. Cote, S.L.R. Kardia, A.S. Wenzlaff, S.J. Land, and A.G. Schwartz
Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study
Carcinogenesis, April 1, 2005; 26(4): 811 - 819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu
An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology
Cancer Res., March 15, 2004; 64(6): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Song, W. Tan, D. Xing, and D. Lin
CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China
Carcinogenesis, January 1, 2001; 22(1): 11 - 16.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.